-
[1]
Chen M.S., Goodman D.W.. The structure of catalytically active gold on Titania[J]. Science,
2004,306:252-255.
doi: 10.1126/science.1102420
-
[2]
Green I.X., Tang W.J., Neurock M., Yates Jr J.T.. Spectroscopic observation of dual catalytic sites during oxidation of CO on a Au/TiO2 catalyst[J]. Science,
2011,333:736-739.
doi: 10.1126/science.1207272
-
[3]
Shaw Ⅲ C.F.. Gold-based therapeutic agents[J]. Chem.Rev.,
1999,99:2589-2600.
doi: 10.1021/cr980431o
-
[4]
Finkelstein A.E., Walz D.T., Batista V.. Auranofin.new oral gold compound for treatment of rheumatoid arthritis[J]. Ann.Rheum.Dis.,
1976,35:251-257.
doi: 10.1136/ard.35.3.251
-
[5]
Fernández-López C., Polavarapu L., Solís D.M.. Gold nanorod-pNIPAM hybrids with reversible Plasmon coupling:synthesis, modeling, and SERS properties[J]. ACS Appl.Mater.Interfaces,
2015,7:12530-12538.
doi: 10.1021/am5087209
-
[6]
Zhang Y., Wang L.M., Tan E.Z.. Uniform arrays of gold nanoparticles with different surface roughness for surface enhanced Raman scattering[J]. Chin. Chem.Lett.,
2015,26:1426-1430.
doi: 10.1016/j.cclet.2015.06.004
-
[7]
Ke X.B., Sarina S., Zhao J.. Tuning the reduction power of supported gold nanoparticle photocatalysts for selective reductions by manipulating the wavelength of visible light irradiation[J]. Chem.Commun.,
2012,48:3509-3511.
doi: 10.1039/c2cc17977f
-
[8]
Kuo W.S., Chang Y.T., Cho K.C.. Gold nanomaterials conjugated with indocyanine green for dual-modality photodynamic and photothermal therapy[J]. Biomaterials,
2012,33:3270-3278.
doi: 10.1016/j.biomaterials.2012.01.035
-
[9]
Jana N.R., Peng X.G.. Single-phase and gram-scale routes toward nearly monodisperse Au and other noble metal nanocrystals[J]. J.Am.Chem.Soc.,
2003,125:14280-14281.
doi: 10.1021/ja038219b
-
[10]
Vigderman L., Zubarev E.R.. High-yield synthesis of gold nanorods with longitudinal SPR peak greater than 1200 nm using hydroquinone as a reducing agent[J]. Chem.Mater.,
2013,25:1450-1457.
doi: 10.1021/cm303661d
-
[11]
Kim D.Y., Yu T., Cho E.C.. Synthesis of gold nano-hexapods with controllable arm lengths and their tunable optical properties[J]. Angew.Chem. Int.Ed.,
2011,50:6328-6331.
doi: 10.1002/anie.201100983
-
[12]
Srinivasan S., Bhardwaj V., Nagasetti A.. Multifunctional surface-enhanced raman spectroscopy-detectable silver nanoparticles for combined photodynamic therapy and pH-triggered chemotherapy[J]. J.Biomed. Nanotechnol.,
2016,12:2202-2219.
doi: 10.1166/jbn.2016.2312
-
[13]
Qiu X., Tang L.C., Dong C.Q.. Characterization of gold nanoparticle bioconjugation by resonance light scattering correlation spectroscopy[J]. Chin. Chem.Lett.,
2010,21:1227-1230.
doi: 10.1016/j.cclet.2010.05.007
-
[14]
Liao J.F., Li W.T., Peng J.R.. Combined cancer photothermal-chemotherapy based on doxorubicin/gold nanorod-loaded polymersomes[J]. Theranostics,
2015,5:345-356.
doi: 10.7150/thno.10731
-
[15]
Peng J.R., Qi T.T., Liao J.F.. Mesoporous magnetic gold nanoclusters as theranostic carrier for chemo-photothermal co-therapy of breast cancer[J]. Theranostics,
2014,4:678-692.
doi: 10.7150/thno.7869
-
[16]
Yavuz M.S., Cheng Y.Y., Chen J.Y.. Gold nanocages covered by smart polymers for controlled release with near-infrared light[J]. Nat.Mater.,
2009,8:935-939.
doi: 10.1038/nmat2564
-
[17]
Wu J.D., Liu B., Wu H.M.. A gold nanoparticle platform for the delivery of functional TGF-β1 siRNA Into cancer cells[J]. J.Biomed.Nanotechnol.,
2016,12:800-810.
doi: 10.1166/jbn.2016.2217
-
[18]
Cheng B., He H.C., Huang T.. Gold nanosphere gated mesoporous silica nanoparticle responsive to near-infrared light and redox potential as a theranostic platform for cancer therapy[J]. J.Biomed.Nanotechnol.,
2016,12:435-449.
doi: 10.1166/jbn.2016.2195
-
[19]
Sun L., Joh D.Y., Al-Zaki A.. Theranostic application of mixed gold and superparamagnetic iron oxide nanoparticle micelles in glioblastoma multiforme[J]. J.Biomed.Nanotechnol.,
2016,12:347-356.
doi: 10.1166/jbn.2016.2173
-
[20]
Kim D., Park S., Lee J.H., Jeong Y.Y., Jon S.. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging[J]. J.Am.Chem.Soc.,
2007,129:7661-7665.
doi: 10.1021/ja071471p
-
[21]
Xu L.G., Liu Y., Chen Z.Y.. Surface-engineered gold nanorods:promising DNA vaccine adjuvant for HIV-1 treatment[J]. Nano Lett.,
2012,12:2003-2012.
doi: 10.1021/nl300027p
-
[22]
Mohammed A.M.. Fabrication and characterization of gold nano particles for DNA biosensor applications[J]. Chin.Chem.Lett.,
2016,27:801-806.
doi: 10.1016/j.cclet.2016.01.013
-
[23]
Fadeel B., Garcia-Bennett A.E.. Better safe than sorry:understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications[J]. Adv.Drug Deliv.Rev.,
2010,62:362-374.
doi: 10.1016/j.addr.2009.11.008
-
[24]
Kagan V.E., Bayir H., Shvedova A.A.. Nanomedicine and nanotoxicology:two sides of the same coin[J]. Nanomedicine,
2005,1:313-316.
doi: 10.1016/j.nano.2005.10.003
-
[25]
Patra H.K., Banerjee S., Chaudhuri U., Lahiri P., Dasgupta A.K.. Cell selective response to gold nanoparticles[J]. Nanomedicine,
2007,3:111-119.
doi: 10.1016/j.nano.2007.03.005
-
[26]
Peng G., Tisch U., Adams O.. Diagnosing lung cancer in exhaled breath using gold nanoparticles[J]. Nat.Nanotechnol.,
2009,4:669-673.
doi: 10.1038/nnano.2009.235
-
[27]
Zhang X.D., Guo M.L., Wu H.Y.. Irradiation stability and cytotoxicity of gold nanoparticles for radiotherapy[J]. Int.J.Nanomed.,
2009,4:165-173.
-
[28]
Sung J.H., Ji J.H., Park J.D.. Subchronic inhalation toxicity of gold nanoparticles[J]. Part.Fibre Toxicol.,
2011,816.
doi: 10.1186/1743-8977-8-16
-
[29]
Mukherjee S., Sau S., Madhuri D.. Green synthesis and characterization of monodispersed gold nanoparticles:toxicity study, delivery of doxorubicin and its bio-distribution in mouse model[J]. J.Biomed.Nanotechnol.,
2016,12:165-181.
doi: 10.1166/jbn.2016.2141
-
[30]
Dreaden E.C., Alkilany A.M., Huang X.H., Murphy C.J., El-Sayed M.A.. The golden age:gold nanoparticles for biomedicine[J]. Chem.Soc.Rev.,
2012,41:2740-2779.
doi: 10.1039/C1CS15237H
-
[31]
Alkilany A.M.. Murphy C.J[J]. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J.Nanopart.Res.,
2010,12:2313-2333.
-
[32]
Khlebtsov N.. Dykman L.Biodistribution and toxicity of engineered gold nanoparticles:a review of in vitro and in vivo studies[J]. Chem.Soc.Rev.,
2011,40:1647-1671.
doi: 10.1039/C0CS00018C
-
[33]
Li J.X., Chang X.L., Chen X.X.. Toxicity of inorganic nanomaterials in biomedical imaging[J]. Biotechnol.Adv.,
2014,32:727-743.
doi: 10.1016/j.biotechadv.2013.12.009
-
[34]
Fischer H.C., Chan W.C.. Nanotoxicity:the growing need for in vivo study[J]. Curr.Opin.Biotechnol.,
2007,18:565-571.
doi: 10.1016/j.copbio.2007.11.008
-
[35]
Jiang W., Kim B.Y.S., Rutka J.T., Chan W.C.W.. Nanoparticle-mediated cellular response is size-dependent[J]. Nat.Nanotechnol.,
2008,3:145-150.
doi: 10.1038/nnano.2008.30
-
[36]
Ahn S., Seo E., Kim K.H.. Physical Property control on the cellular uptake pathway and spatial distribution of nanoparticles in cells[J]. J.Biomed. Nanotechnol.,
2015,11:1051-1070.
doi: 10.1166/jbn.2015.2037
-
[37]
Osaki F., Kanamori T., Sando S., Sera T., Aoyama Y.. A quantum dot conjugated sugar ball and its cellular uptake.On the size effects of endocytosis in the subviral region[J]. J.Am.Chem.Soc.,
2004,126:6520-6521.
doi: 10.1021/ja048792a
-
[38]
Lu F., Wu S.H., Hung Y., Mou C.Y.. Size effect on cell uptake in well-suspended: uniform mesoporous silica nanoparticles[J]. Small,
2009,5:1408-1413.
doi: 10.1002/smll.v5:12
-
[39]
Ma X.W., Wu Y.Y., Jin S.B.. Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment[J]. ACS Nano,
2011,5:8629-8639.
doi: 10.1021/nn202155y
-
[40]
Chithrani B.D., Ghazani A.A., Chan W.C.W.. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells[J]. Nano Lett.,
2006,6:662-668.
doi: 10.1021/nl052396o
-
[41]
Pan Y., Neuss S., Leifert A.. Size-dependent cytotoxicity of gold nanoparticles[J]. Small,
2007,3:1941-1949.
doi: 10.1002/(ISSN)1613-6829
-
[42]
Pan Y., Leifert A., Ruau D.. Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage[J]. Small,
2009,5:2067-2076.
doi: 10.1002/smll.v5:18
-
[43]
Senut M.C., Zhang Y.H., Liu F.C.. Size-dependent toxicity of gold nanoparticles on human embryonic stem cells and their neural derivatives[J]. Small,
2016,12:631-646.
doi: 10.1002/smll.v12.5
-
[44]
Yen H.J., Hsu S.H., Tsai C.L.. Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes[J]. Small,
2009,5:1553-1561.
doi: 10.1002/smll.v5:13
-
[45]
Freese C., Uboldi C., Gibson M.I.. Uptake and cytotoxicity of citrate-coated gold nanospheres:comparative studies on human endothelial and epithelial cells[J]. Part.Fibre.Toxicol.,
2012,923.
doi: 10.1186/1743-8977-9-23
-
[46]
Vijayakumar S., Ganesan S.. In vitro cytotoxicity assay on gold nanoparticles with different stabilizing agents[J]. J.Nanomater.,
2012,2012734398.
-
[47]
Choi S.Y., Jeong S., Jang S.H.. In vitro toxicity of serum protein-adsorbed citrate-reduced gold nanoparticles in human lung adenocarcinoma cells[J]. Toxicol.Vitro,
2012,26:229-237.
doi: 10.1016/j.tiv.2011.11.016
-
[48]
Mironava T., Hadjiargyrou M., Simon M., Jurukovski V., Rafailovich M.H.. Gold nanoparticles cellular toxicity and recovery:effect of size, concentration and exposure time[J]. Nanotoxicology,
2010,4:120-137.
doi: 10.3109/17435390903471463
-
[49]
Li Z.B., Tang S.Y., Wang B.K.. Metabolizable small gold nanorods:size-dependent cytotoxicity, cell uptake and in vivo biodistribution[J]. ACS Biomater. Sci.Eng.,
2016,2:789-797.
doi: 10.1021/acsbiomaterials.5b00538
-
[50]
Qu Y.H., Lü X.Y.. Aqueous synthesis of gold nanoparticles and their cytotoxicity in human dermal fibroblasts-fetal[J]. Biomed.Mater.,
2009,4025007.
doi: 10.1088/1748-6041/4/2/025007
-
[51]
Coradeghini R., Gioria S., García C.P.. Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblasts[J]. Toxicol. Lett.,
2013,217:205-216.
doi: 10.1016/j.toxlet.2012.11.022
-
[52]
Wang L.M., Jiang X.M., Ji Y.L.. Surface chemistry of gold nanorods:origin of cell membrane damage and cytotoxicity[J]. Nanoscale,
2013,58384.
doi: 10.1039/c3nr01626a
-
[53]
Alkilany A.M., Nagaria P.K., Hexel C.R.. Cellular uptake and cytotoxicity of gold nanorods:molecular origin of cytotoxicity and surface effects[J]. Small,
2009,5:701-708.
doi: 10.1002/smll.v5:6
-
[54]
Alkilany A.M., Shatanawi A., Kurtz T., Caldwell R.B., Caldwell R.W.. Toxicity and cellular uptake of gold nanorods in vascular endothelium and smooth muscles of isolated rat blood vessel:importance of surface modification[J]. Small,
2012,8:1270-1278.
doi: 10.1002/smll.201101948
-
[55]
Takahashi H., Niidome Y., Niidome T.. Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity[J]. Langmuir,
2006,22:2-5.
doi: 10.1021/la0520029
-
[56]
Murphy C.J., Gole A.M., Stone J.W.. Gold nanoparticles in biology: beyond toxicity to cellular imaging[J]. Acc.Chem.Res.,
2008,41:1721-1730.
doi: 10.1021/ar800035u
-
[57]
Niidome T., Yamagata M., Okamoto Y.. PEG-modifled gold nanorods with a stealth character for in vivo applications[J]. J.Control.Release,
2006,114:343-347.
doi: 10.1016/j.jconrel.2006.06.017
-
[58]
Uboldi C., Bonacchi D., Lorenzi G.. Gold nanoparticles induce cytotoxicity in the alveolar type-Ⅱ cell lines A549 and NCIH441[J]. Part.Fibre Toxicol.,
2009,618.
doi: 10.1186/1743-8977-6-18
-
[59]
Freese C., Uboldi C., Gibson M.. Uptake and cytotoxicity of citrate-coated gold nanospheres:comparative studies on human endothelial and epithelial cells[J]. Part.Fibre Toxicol.,
2012,923.
doi: 10.1186/1743-8977-9-23
-
[60]
Chompoosor A., Saha K., Ghosh P.S.. The role of surface functionality on acute cytotoxicity, ROS generation and DNA damage by cationic gold nanoparticles[J]. Small,
2010,6:2246-2249.
doi: 10.1002/smll.v6:20
-
[61]
P.del Pino, Yang F., Pelaz B.. Basic physicochemical properties of polyethylene glycol coated gold nanoparticles that determine their interaction with cells[J]. Angew.Chem.Int.Ed.,
2016,55:5483-5487.
doi: 10.1002/anie.201511733
-
[62]
Uz M., Bulmus V., Altinkaya S.A.. Effect of PEG grafting density and hydrodynamic volume on gold nanoparticle-cell interactions:an investigation on cell cycle, apoptosis, and DNA damage[J]. Langmuir,
2016,32:5997-6009.
doi: 10.1021/acs.langmuir.6b01289
-
[63]
Leite P.E.C., Pereira M.R., Santos C.A.D.N.. Gold nanoparticles do not induce myotube cytotoxicity but increase the susceptibility to cell death[J]. Toxicol.Vitro,
2015,29:819-827.
doi: 10.1016/j.tiv.2015.02.010
-
[64]
Brandenberger C., C.Mühlfeld , Ali Z.. Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles[J]. Small,
2010,6:1669-1678.
doi: 10.1002/smll.v6:15
-
[65]
Yasun E., Li C.M., Barut I.. BSA modification to reduce CTAB induced nonspecificity and cytotoxicity of aptamer-conjugated gold nanorods[J]. Nanoscale,
2015,7:10240-10248.
doi: 10.1039/C5NR01704A
-
[66]
Wang L.M., Li J.Y., Pan J.. Revealing the binding structure of the protein corona on gold nanorods using synchrotron radiation-based techniques: understanding the reduced damage in cell membranes[J]. J.Am.Chem.Soc.,
2013,135:17359-17368.
doi: 10.1021/ja406924v
-
[67]
Au L., Zhang Q., Cobley C.M.. Quantifying the cellular uptake of antibody-conjugated au nanocages by two-photon microscopy and inductively coupled plasma mass spectrometry[J]. ACS Nano,
2010,4:35-42.
doi: 10.1021/nn901392m
-
[68]
Yue Z.G., Wei W., Lv P.P.. Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles[J]. Biomacromolecules,
2011,12:2440-2446.
doi: 10.1021/bm101482r
-
[69]
Goodman C.M., McCusker C.D., Yilmaz T., Rotello V.M.. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains[J]. Bioconjugate Chem.,
2004,15:897-900.
doi: 10.1021/bc049951i
-
[70]
Arvizo R.R., Miranda O.R., Thompson M.A.. Effect of nanoparticle surface charge at the plasma membrane and beyond[J]. Nano Lett.,
2010,10:2543-2548.
doi: 10.1021/nl101140t
-
[71]
Wang Y.C., Black K.C.L., Luehmann H.. Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment[J]. ACS Nano,
2013,7:2068-2077.
doi: 10.1021/nn304332s
-
[72]
Li Y., Kröger M., Liu W.K.. Shape effect in cellular uptake of PEGylated nanoparticles:comparison between sphere, rod, cube and disk[J]. Nanoscale,
2015,7:16631-16646.
doi: 10.1039/C5NR02970H
-
[73]
Li Y., Yue T.T., Yang K., Zhang X.R.. Molecular modeling of the relationship between nanoparticle shape anisotropy and endocytosis kinetics[J]. Biomaterials,
2012,33:4965-4973.
doi: 10.1016/j.biomaterials.2012.03.044
-
[74]
Nangia S., Sureshkumar R.. Effects of nanoparticle charge and shape anisotropy on translocation through cell membranes[J]. Langmuir,
2012,28:17666-17671.
doi: 10.1021/la303449d
-
[75]
Wang Z.J., Xie D., Liu H.Z., Bao Z.H., Wang Y.J.. Toxicity assessment of precise engineered gold nanoparticles with different shapes in zebrafish embryos[J]. RSC Adv.,
2016,6:33009-33013.
doi: 10.1039/C6RA00632A
-
[76]
Karakoçak B.B., Raliya R., Davis J.T.. Biocompatibility of gold nanoparticles in retinal pigment epithelial cell line[J]. Toxicol.In Vitro,
2016,37:61-69.
doi: 10.1016/j.tiv.2016.08.013
-
[77]
Favi P.M., Gao M., Arango L.J.S.. Shape and surface effects on the cytotoxicity of nanoparticles:gold nanospheres versus gold nanostars[J]. J. Biomed.Mater.Res.A,
2015,103:3449-3462.
doi: 10.1002/jbm.v103.11
-
[78]
Wan J., Wang J.H., Liu T.. Surface chemistry but not aspect ratio mediates the biological toxicity of gold nanorods in vitro and in vivo[J]. Sci.Rep.,
2015,511398.
doi: 10.1038/srep11398
-
[79]
Black K.C.L., Wang Y.C., Luehmann H.P.. Radioactive 198Au-Doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution[J]. ACS Nano,
2014,8:4385-4394.
doi: 10.1021/nn406258m
-
[80]
Hillyer J.F., Albrecht R.M.. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles[J]. J.Pharm.Sci.,
2001,90:1927-1936.
doi: 10.1002/jps.1143
-
[81]
Balogh L., Nigavekar S.S., Nair B.M.. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models[J]. Nanomedicine,
2007,3:281-296.
doi: 10.1016/j.nano.2007.09.001
-
[82]
W.H.De Jong, Hagens W.I., Krystek P.. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration[J]. Biomaterials,
2008,29:1912-1919.
doi: 10.1016/j.biomaterials.2007.12.037
-
[83]
Hirn S., M.Semmler-Behnke , Schleh C.. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration[J]. Eur.J.Pharm.Biopharm.,
2011,77:407-416.
doi: 10.1016/j.ejpb.2010.12.029
-
[84]
Schleh C., M.Semmler-Behnke , Lipka J.. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration[J]. Nanotoxicology,
2012,6:36-46.
doi: 10.3109/17435390.2011.552811
-
[85]
Zhang X.D., Wu D., Shen X.. Size-dependent in vivo toxicity of PEG-coated gold nanoparticles[J]. Int.J.Nanomed.,
2011,6:2071-2081.
-
[86]
M.Pannerec-Varna , Ratajczak P., Bousquet G.. In vivo uptake and cellular distribution of gold nanoshells in a preclinical model of xenografted human renal cancer[J]. Gold Bull.,
2013,46:257-265.
doi: 10.1007/s13404-013-0115-8
-
[87]
Wang L.M., Li Y.F., Zhou L.J.. Characterization of gold nanorods in vivo by integrated analytical techniques:their uptake, retention, and chemical forms[J]. Anal.Bioanal.Chem.,
2010,396:1105-1114.
doi: 10.1007/s00216-009-3302-y
-
[88]
Akiyama Y., Mori T., Katayama Y., Niidome T.. The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice[J]. J.Control.Release,
2009,139:81-84.
doi: 10.1016/j.jconrel.2009.06.006
-
[89]
Lee U., Yoo C.J., Kim Y.J., Yoo Y.M.. Cytotoxicity of gold nanoparticles in human neural precursor cells and rat cerebral cortex[J]. J.Biosci.Bioeng.,
2016,121:341-344.
doi: 10.1016/j.jbiosc.2015.07.004
-
[90]
Sadauskas E., Danscher G., Stoltenberg M.. Protracted elimination of gold nanoparticles from mouse liver[J]. Nanomedicine,
2009,5:162-169.
doi: 10.1016/j.nano.2008.11.002
-
[91]
Cho W.S., Cho M., Jeong J.. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles[J]. Toxicol.Appl.Pharmacol.,
2009,36:16-24.
-
[92]
Wang J.Y., Chen J., Yang J.. Effects of surface charges of gold nanoclusters on long-term in vivo biodistribution toxicity, and cancer radiation therapy[J]. Int.J.Nanomed.,
2016,11:3475-3485.
doi: 10.2147/IJN
-
[93]
Sereemaspun A., Rojanathanes R., Wiwanitkit V.. Effect of gold nanoparticle on renal cell:an implication for exposure risk[J]. Ren.Fail.,
2008,30:323-325.
doi: 10.1080/08860220701860914
-
[94]
Abdelhalim M.A.K., Jarrar B.M.. Renal tissue alterations were size-dependent with smaller ones induced more effects and related with time exposure of gold nanoparticles[J]. Lipids Health Dis.,
2011,10163.
doi: 10.1186/1476-511X-10-163
-
[95]
Zhang X.D., Wu H.Y., Wu D.. Toxicologic effects of gold nanoparticles in vivo by different administration routes[J]. Int.J.Nanomed.,
2010,5:771-781.
-
[96]
Balasubramanian S.K., Jittiwat J., Manikandan J.. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats[J]. Biomaterials,
2010,31:2034-2042.
doi: 10.1016/j.biomaterials.2009.11.079
-
[97]
Shi X.L., Zhu Y.T., Hua W.D.. An in vivo study of the biodistribution of gold nanoparticles after intervaginal space injection in the tarsal tunnel[J]. Nano Res.,
2016,9:2097-2109.
doi: 10.1007/s12274-016-1100-3
-
[98]
Lipka J., Semmler-Behnke M., Sperling R.A.. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection[J]. Biomaterials,
2010,31:6574-6581.
doi: 10.1016/j.biomaterials.2010.05.009
-
[99]
Rambanapasi C., Zeevaart J.R., Buntting H.. Bioaccumulation and subchronic toxicity of 14 nm gold nanoparticles in rats[J]. Molecules,
2016,21763.
doi: 10.3390/molecules21060763
-
[100]
C.Lasagna-Reeves , D.Gonzalez-Romero , Barria M.A.. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice[J]. Biochem.Biophys.Res.Commun.,
2010,393:649-655.
doi: 10.1016/j.bbrc.2010.02.046
-
[101]
M.Semmler-Behnke , Kreyling W.G., Lipka J.. Biodistribution of 1.4-and 18-nm gold particles in rats[J]. Small,
2008,4:2108-2111.
doi: 10.1002/smll.v4:12
-
[102]
O.Bar-Ilan , Albrecht R.M., Fako V.E., Furgeson D.Y.. Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos[J]. Small,
2009,5:1897-1910.
doi: 10.1002/smll.v5:16
-
[103]
Shukla R., Bansal V., Chaudhary M.. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview[J]. Langmuir,
2005,21:10644-10654.
doi: 10.1021/la0513712
-
[104]
Liu Z.M., Li W.Q., Wang F.. Enhancement of lipopolysaccharide-induced nitric oxide and interleukin-6 production by PEGylated gold nanoparticles in RAW264.7 cells[J]. Nanoscale,
2012,47135.
doi: 10.1039/c2nr31355c
-
[105]
Brandenberger C., Rothen-Rutishauser B., Mühlfeld C.. Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model[J]. Toxicol.Appl.Pharmacol.,
2010,242:56-65.
doi: 10.1016/j.taap.2009.09.014
-
[106]
Bastu's N.G., Sánchez-Tilló E., Pujals S.. Homogeneous conjugation of peptides onto gold nanoparticles enhances macrophage response[J]. ACS Nano,
2009,3:1335-1344.
doi: 10.1021/nn8008273
-
[107]
Cheung K.L., Chen H.J., Chen Q.L.. CTAB-coated gold nanorods elicit allergic response through degranulation and cell death in human basophils[J]. Nanoscale,
2012,4:4447-4449.
doi: 10.1039/c2nr30435j
-
[108]
Jia H.Y., Liu Y., Zhang X.J.. Potential oxidative stress of gold nanoparticles by induced-NO releasing in serum[J]. J.Am.Chem.Soc.,
2009,131:40-41.
doi: 10.1021/ja808033w
-
[109]
Iswarya V., Manivannan J., De A.. Surface capping and size-dependent toxicity of gold nanoparticles on different trophic levels[J]. Environ.Sci.Pollut. Res.,
2016,23:4844-4858.
doi: 10.1007/s11356-015-5683-0
-
[110]
Li J.J., Hartono D., Ong C.N., Bay B.H., Yung L.Y.L.. Autophagy and oxidative stress associated with gold nanoparticles[J]. Biomaterials,
2010,31:5996-6003.
doi: 10.1016/j.biomaterials.2010.04.014
-
[111]
Ding F.G., Li Y.P., Liu J.. Overendocytosis of gold nanoparticles increases autophagy and apoptosis in hypoxic human renal proximal tubular cells[J]. Int. J.Nanomed.,
2014,9:4317-4330.
-
[112]
Tsai Y.Y., Huang Y.H., Chao Y.L.. Identification of the nanogold particle-induced endoplasmic reticulum stress by omic techniques and systems biology analysis[J]. ACS Nano,
2011,5:9354-9369.
doi: 10.1021/nn2027775
-
[113]
Ramalingam V., Revathidevi S., Shanmuganayagam T., Muthulakshmi L., Rajaram R.. Biogenic gold nanoparticles induce cell cycle arrest through oxidative stress and sensitize mitochondrial membranes in A549 lung cancer cells[J]. RSC Adv.,
2016,6:20598-20608.
doi: 10.1039/C5RA26781A
-
[114]
Wang L.M., Liu Y., Li W.. Selective targeting of gold nanorods at the mitochondria of cancer cells:implications for cancer therapy[J]. Nano Lett.,
2011,11:772-780.
doi: 10.1021/nl103992v
-
[115]
Chithrani B.D., Chan W.C.W.. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes[J]. Nano Lett.,
2007,7:1542-1550.
doi: 10.1021/nl070363y
-
[116]
Grace Nirmala J., Akila S., Muthukumar Nadar M.S.A., Narendhirakannan R.T., Chatterjeeb S.. Biosynthesized Vitis vinifera seed gold nanoparticles Induce apoptotic cell death in A431 skin cancer cells[J]. RSC Adv.,
2016,6:82205-82218.
doi: 10.1039/C6RA16310F
-
[117]
Tsoli M., Kuhn H., Brandau W., Esche H., Schmid G.. Cellular uptake and toxicity of Au55 clusters[J]. Small,
2005,1:841-844.
doi: 10.1002/(ISSN)1613-6829
-
[118]
Chuang S.M., Lee Y.H., Liang R.Y.. Extensive evaluations of the cytotoxic effects of gold nanoparticles[J]. Biochim.Biophys.Acta,
2013,1830:4960-4973.
doi: 10.1016/j.bbagen.2013.06.025